Kent Riemondy

University of Colorado Anschutz Medical Campus

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study”.

Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study

Neuro-Oncology(2023)10.1093/neuonc/noad096

N/A

0DataRank · unranked

21 citations

Kelsey C. Bertrand, Kent Riemondy, Dexiang Gao, Yonghua Zhuang, Bridget Sanford +17 more

Multi‐pronged analysis of pediatric low‐grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations

Brain Pathology(2025)10.1111/bpa.70023

N/A

0DataRank · unranked

2 citations

Kent Riemondy, Tian Liu, Andrea M. Griesinger, Andrew M. Donson, April A. Apfelbaum +15 more